213 related articles for article (PubMed ID: 23229317)
21. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Hemphill A
Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
Srinivasan S; Mueller J; Suana A; Hemphill A
J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
[TBL] [Abstract][Full Text] [Related]
23. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
Tuo W; Zhao Y; Zhu D; Jenkins MC
Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
[TBL] [Abstract][Full Text] [Related]
24. The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis.
Bengoa-Luoni SA; Corigliano MG; Sánchez-López E; Albarracín RM; Legarralde A; Ganuza A; Clemente M; Sander VA
Acta Trop; 2019 Oct; 198():105094. PubMed ID: 31323195
[TBL] [Abstract][Full Text] [Related]
25. Gene cloning and characterization of the protein encoded by the Neospora caninum bradyzoite-specific antigen gene BAG1.
Kobayashi T; Narabu S; Yanai Y; Hatano Y; Ito A; Imai S; Ike K
J Parasitol; 2013 Jun; 99(3):453-8. PubMed ID: 23245337
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
[TBL] [Abstract][Full Text] [Related]
27. Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
Pinheiro AF; Roloff BC; da Silveira Moreira A; Berne MEA; Silva RA; Leite FPL
Vaccine; 2018 Feb; 36(9):1154-1159. PubMed ID: 29395519
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
[TBL] [Abstract][Full Text] [Related]
29. Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle.
Nishimura M; Kohara J; Kuroda Y; Hiasa J; Tanaka S; Muroi Y; Kojima N; Furuoka H; Nishikawa Y
Vaccine; 2013 Aug; 31(35):3528-35. PubMed ID: 23742998
[TBL] [Abstract][Full Text] [Related]
30. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
[TBL] [Abstract][Full Text] [Related]
31. ArtinM, a D-mannose-binding lectin from Artocarpus integrifolia, plays a potent adjuvant and immunostimulatory role in immunization against Neospora caninum.
Cardoso MR; Mota CM; Ribeiro DP; Santiago FM; Carvalho JV; Araujo EC; Silva NM; Mineo TW; Roque-Barreira MC; Mineo JR; Silva DA
Vaccine; 2011 Nov; 29(49):9183-93. PubMed ID: 22001880
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice.
Baszler TV; Long MT; McElwain TF; Mathison BA
Int J Parasitol; 1999 Oct; 29(10):1635-46. PubMed ID: 10608450
[TBL] [Abstract][Full Text] [Related]
33. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
[TBL] [Abstract][Full Text] [Related]
34. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus.
Nishikawa Y; Kousaka Y; Fukumoto S; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
Parasitol Res; 2000 Nov; 86(11):934-9. PubMed ID: 11097303
[TBL] [Abstract][Full Text] [Related]
35. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
[TBL] [Abstract][Full Text] [Related]
36. Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
Xu J; Hiramatsu R; Suhaimi H; Kato T; Fujimoto A; Tokiwa T; Ike K; Park EY
Vaccine; 2019 Oct; 37(43):6426-6434. PubMed ID: 31515150
[TBL] [Abstract][Full Text] [Related]
37. Vaccine development against Neospora caninum infection.
Nishikawa Y; Mikami T; Nagasawa H
J Vet Med Sci; 2002 Jan; 64(1):1-5. PubMed ID: 11853138
[TBL] [Abstract][Full Text] [Related]
38. A POLYGEN-adjuvanted killed Neospora caninum tachyzoite preparation failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental tachyzoite challenge.
Andrianarivo AG; Rowe JD; Barr BC; Anderson ML; Packham AE; Sverlow KW; Choromanski L; Loui C; Grace A; Conrad PA
Int J Parasitol; 2000 Aug; 30(9):985-90. PubMed ID: 10980287
[TBL] [Abstract][Full Text] [Related]
39. Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice.
Aguado-Martínez A; Basto AP; Tanaka S; Ryser LT; Nunes TP; Ortega-Mora LM; Arranz-Solís D; Leitão A; Hemphill A
Vaccine; 2019 Jan; 37(3):473-483. PubMed ID: 30497830
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
